Hong Kong Stock Exchange · Healthcare
Invest in Sichuan Kelun-Biotech Biopharmaceutical stock from India
Indian and foreign residents can buy Sichuan Kelun-Biotech Biopharmaceutical (6990) shares directly through Paasa.
By Paasa · Updated
Sichuan Kelun-Biotech Biopharmaceutical at a glance
- Price
- HK$487.00+HK$14.00 (2.96%)
- Market cap
- HK$113.56B
- Day range
- HK$465.20 – HK$497.80
- P/E
- 757.83
- Dividend yield
- None
- Volume
- 852.70K
- 1 month
- -2.05%
- 6 months
- +5.87%
- YTD
- +23.79%
- 1 year
- -5.25%
- 5 years
- —
Sichuan Kelun-Biotech Biopharmaceutical statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | CN¥2.1B | CN¥1.9B | CN¥1.5B | CN¥803.9M | CN¥31.8M |
| Gross profit | CN¥1.5B | CN¥1.3B | CN¥759.2M | CN¥527.1M | −CN¥10.9M |
| Operating income | −CN¥466.2M | −CN¥211.4M | −CN¥452.6M | −CN¥393.9M | −CN¥798.8M |
| Net income | −CN¥382.0M | −CN¥266.8M | −CN¥574.1M | −CN¥616.1M | −CN¥875.3M |
| Earnings per share | −CN¥1.66 | −CN¥1.20 | −CN¥2.84 | −CN¥2.54 | −CN¥8.75 |
| EBITDA | −CN¥249.2M | −CN¥47.4M | −CN¥308.3M | −CN¥351.2M | −CN¥776.2M |
| Total assets | CN¥6.0B | CN¥4.3B | CN¥3.5B | CN¥993.1M | CN¥997.0M |
| Total debt | CN¥88.4M | CN¥126.7M | CN¥59.9M | CN¥3.0B | CN¥2.9B |
| Cash and short-term investments | CN¥4.6B | CN¥3.1B | CN¥2.5B | CN¥105.3M | CN¥100.3M |
| Shareholders' equity | CN¥4.9B | CN¥3.3B | CN¥2.3B | −CN¥3.2B | −CN¥3.2B |
| Operating cash flow | −CN¥180.3M | −CN¥429.8M | CN¥59.6M | −CN¥270.8M | −CN¥517.2M |
| Free cash flow | −CN¥306.6M | −CN¥510.9M | −CN¥22.7M | −CN¥309.8M | −CN¥609.7M |
| Capital expenditure | −CN¥126.3M | −CN¥81.1M | −CN¥82.3M | −CN¥39.0M | −CN¥92.5M |
Fiscal years as reported, the latest ending 31 Dec 2025. Figures in CNY; a dash means the provider reported nothing for that line.
How to invest in Sichuan Kelun-Biotech Biopharmaceutical from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to HKD when you buy.
Step 3
Search 6990 and buy
Find Sichuan Kelun-Biotech Biopharmaceutical by name or by its ticker, 6990, and place your order. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
Why invest in Sichuan Kelun-Biotech Biopharmaceutical from India
What Sichuan Kelun-Biotech Biopharmaceutical does
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally. The company’s product pipeline includes Sac-TMT, a novel TROP2 ADC positioned as a monotherapy and part of combination therapies for treating various advanced solid tumors; Trastuzumab botidotin, a monotherapy to treat advanced HER2+ solid tumors; SKB315, a novel CLDN18.2 ADC targeting advanced solid tu… Sichuan Kelun-Biotech Biopharmaceutical operates in the Biotechnology industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Sichuan Kelun-Biotech Biopharmaceutical stock from India?
Yes. Indian residents and NRIs can buy Sichuan Kelun-Biotech Biopharmaceutical (6990) shares directly through Paasa. Sichuan Kelun-Biotech Biopharmaceutical is listed on the Hong Kong Stock Exchange, in the Biotechnology industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
Do I need to buy a full Sichuan Kelun-Biotech Biopharmaceutical share?
Usually more than one, and not a fraction: many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. At HK$487.00 a share, size the order by the lot, not by the share.
How are Sichuan Kelun-Biotech Biopharmaceutical dividends taxed for Indian investors?
Sichuan Kelun-Biotech Biopharmaceutical trades on the Hong Kong Stock Exchange but is domiciled in China, so any withholding on its dividends follows that country's rules rather than those of Hong Kong. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.
What tax do I pay in India when I sell Sichuan Kelun-Biotech Biopharmaceutical shares?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the HKD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.